
Manufacturers must address scale-out challenges of autologous cell therapy for commercial manufacturing.
Francesca McBride is director of Regulatory Compliance at Jacobs, Francesca.McBride@Jacobs.com.

Manufacturers must address scale-out challenges of autologous cell therapy for commercial manufacturing.

Published: July 1st 2020 | Updated: